Business · 03/06/1994Updated: 10/16/2026 · 1 min read
FDA Conducts Review of General Biologics and Licensing Regulations
The Food and Drug Administration (FDA) is reviewing general biologics and licensing regulations, seeking public comment to identify outdated or unnecessary regulations.
Original source language: Federal Register — Health and Human ServicesOpen original release →